Aquyre Biosciences Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $24M
Latest Deal Amount
  • Investors
  • 6

Aquyre Biosciences General Information

Description

Developer of cellular level optical biopsies imaging systems designed to provide immediate biopsies results to avoid the delay of receiving a report. The company's systems provide cellular resolution imaging services, enabling researchers to conduct non-invasive and nondestructive optical biopsies using light to take optical biopsies beneath the surface of the tissue under analysis.

Contact Information

Website
www.lltech.co
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Other Devices and Supplies
Primary Office
  • 103 Carnegie Center Drive
  • Princeton, NJ 08340
  • United States
+1 (609) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aquyre Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 19-Oct-2020 $24M 0000 0000 Completed Generating Revenue
5. Secondary Transaction - Private 000 Completed Generating Revenue
4. Later Stage VC 12-Jul-2013 000 Completed Generating Revenue
3. Early Stage VC 01-Jul-2011 000 000 Completed Startup
2. Grant 01-Jun-2011 $3.2M Completed Startup
1. Corporate Completed Startup
To view Aquyre Biosciences’s complete valuation and funding history, request access »

Aquyre Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-4 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-3 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-2 0,000,000 00.000000 000.0 000.0 00 000.0 00.000
Series A-1 94,195 $0.000100 $8.1 $8.1 1x $8.1 2.45%
Series A 110,000 $0.000100 $13.5 $13.5 1x $13.5 2.3%
To view Aquyre Biosciences’s complete cap table history, request access »

Aquyre Biosciences Executive Team (5)

Name Title Board Seat Contact Info
Bertrand Le Conte de Poly Co-Founder & Chief Executive Officer
Claude Boccara Co-Founder & Chief Scientific Officer
You’re viewing 2 of 5 executive team members. Get the full list »

Aquyre Biosciences Board Members (3)

Name Representing Role Since
Michael Albin Ph.D Aquyre Biosciences Board Member 000 0000
Thierry Thaure Aquyre Biosciences Board Member 000 0000
Xavier Buttes Aquyre Biosciences Board Member 000 0000
To view Aquyre Biosciences’s complete board members history, request access »

Aquyre Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aquyre Biosciences Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alberto Chalon Angel (individual) Minority 000 0000 000000 0
Embassy of France Government 000 0000 000000 0
European Union Government 000 0000 000000 0
Institut National du Cancer Government 000 0000 000000 0
L'Agence Nationale de la Recherche Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »